Stocks to Watch: Adobe, RH, Singular Genomics Systems, Immuneering
Adobe's fiscal Q4 outlook fell short of analyst estimates, with projected revenue and earnings below expectations despite increased profit and revenue in Q3 driven by AI products. Stock price dropped 8.8% in after-hours trading to $534.75.